000 | 01972 a2200529 4500 | ||
---|---|---|---|
005 | 20250516105220.0 | ||
264 | 0 | _c20121025 | |
008 | 201210s 0 0 ger d | ||
022 | _a1439-4413 | ||
024 | 7 |
_a10.1055/s-0032-131866 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPommer, Peter | |
245 | 0 | 0 |
_a[A single tablet against HIV: new combination preparation improves therapy]. _h[electronic resource] |
260 |
_bDeutsche medizinische Wochenschrift (1946) _cAug 2012 |
||
300 |
_a1673 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; News | ||
650 | 0 | 4 |
_aAdenine _xadministration & dosage |
650 | 0 | 4 | _aAlkynes |
650 | 0 | 4 |
_aAnti-HIV Agents _xadministration & dosage |
650 | 0 | 4 |
_aAntiretroviral Therapy, Highly Active _xadverse effects |
650 | 0 | 4 | _aAtazanavir Sulfate |
650 | 0 | 4 |
_aBenzoxazines _xadministration & dosage |
650 | 0 | 4 | _aCD4 Lymphocyte Count |
650 | 0 | 4 |
_aCarbamates _xadministration & dosage |
650 | 0 | 4 | _aClinical Trials, Phase III as Topic |
650 | 0 | 4 | _aCobicistat |
650 | 0 | 4 | _aCyclopropanes |
650 | 0 | 4 |
_aDeoxycytidine _xadministration & dosage |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aDrug Combinations |
650 | 0 | 4 | _aDrug Resistance, Viral |
650 | 0 | 4 | _aEmtricitabine |
650 | 0 | 4 | _aGlomerular Filtration Rate |
650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aOligopeptides _xadministration & dosage |
650 | 0 | 4 |
_aOrganophosphonates _xadministration & dosage |
650 | 0 | 4 |
_aPyridines _xadministration & dosage |
650 | 0 | 4 |
_aQuinolones _xadministration & dosage |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 |
_aRitonavir _xadministration & dosage |
650 | 0 | 4 | _aTenofovir |
650 | 0 | 4 |
_aThiazoles _xadministration & dosage |
650 | 0 | 4 | _aViral Load |
773 | 0 |
_tDeutsche medizinische Wochenschrift (1946) _gvol. 137 _gno. 34-35 _gp. 1673 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-0032-131866 _zAvailable from publisher's website |
999 |
_c22025024 _d22025024 |